KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to -$18.6 million.

  • Pacific Biosciences Of California's Free Cash Flow rose 5831.99% to -$18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$126.3 million, marking a year-over-year increase of 4729.57%. This contributed to the annual value of -$212.2 million for FY2024, which is 2080.85% up from last year.
  • Per Pacific Biosciences Of California's latest filing, its Free Cash Flow stood at -$18.6 million for Q3 2025, which was up 5831.99% from -$29.9 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Free Cash Flow registered a high of -$17.3 million during Q2 2021, and its lowest value of -$98.4 million during Q1 2023.
  • Its 5-year average for Free Cash Flow is -$51.1 million, with a median of -$45.4 million in 2025.
  • As far as peak fluctuations go, Pacific Biosciences Of California's Free Cash Flow tumbled by 27371.68% in 2022, and later surged by 5831.99% in 2025.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Free Cash Flow stood at -$34.6 million in 2021, then plummeted by 89.49% to -$65.5 million in 2022, then rose by 8.99% to -$59.6 million in 2023, then surged by 45.85% to -$32.3 million in 2024, then soared by 42.29% to -$18.6 million in 2025.
  • Its Free Cash Flow was -$18.6 million in Q3 2025, compared to -$29.9 million in Q2 2025 and -$45.4 million in Q1 2025.